These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Plasma atrial natriuretic peptide levels and their clinical importance in infant with pneumonia associated with congestive heart failure]. Guo Z Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):130-2, 10. PubMed ID: 2163735 [TBL] [Abstract][Full Text] [Related]
4. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators. Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729 [TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235 [TBL] [Abstract][Full Text] [Related]
6. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure. Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855 [TBL] [Abstract][Full Text] [Related]
7. Plasma levels of adrenomedullin and atrial natriuretic peptide in patients with congestive heart failure of various etiologies. Randa Abdel Kader M; Grace BD; Badawi NE Ital J Biochem; 2007 Mar; 56(1):18-27. PubMed ID: 17511350 [TBL] [Abstract][Full Text] [Related]
8. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease. Yeh JL; Hsu JH; Dai ZK; Liou SF; Chen IJ; Wu JR Int J Cardiol; 2005 Sep; 104(1):15-20. PubMed ID: 16055212 [TBL] [Abstract][Full Text] [Related]
9. [Estimation of cardiac function by plasma concentration of brain natriuretic peptide in patients with Duchenne muscular dystrophy]. Kashiwagi S; Akaike M; Kawai H; Adachi K; Saito S Rinsho Shinkeigaku; 1996 Jan; 36(1):7-11. PubMed ID: 8689797 [TBL] [Abstract][Full Text] [Related]
10. Plasma levels of atrial natriuretic peptide in patients with Duchenne's progressive muscular dystrophy. Yanagisawa A; Yokota N; Miyagawa M; Kawamura J; Ishihara T; Aoyagi T; Ishikawa K Am Heart J; 1990 Nov; 120(5):1154-8. PubMed ID: 2146865 [TBL] [Abstract][Full Text] [Related]
11. Cardioprotection for Duchenne's muscular dystrophy. Ishikawa Y; Bach JR; Minami R Am Heart J; 1999 May; 137(5):895-902. PubMed ID: 10220639 [TBL] [Abstract][Full Text] [Related]
12. Secretion and clinical significance of atrial natriuretic peptide in patients with muscular dystrophy. Kawai H; Adachi K; Kimura C; Nishiuchi T; Yamasaki Y; Tsutsui Y; Saito S Arch Neurol; 1990 Aug; 47(8):900-4. PubMed ID: 2142880 [TBL] [Abstract][Full Text] [Related]
13. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745 [TBL] [Abstract][Full Text] [Related]
14. [Effective milrinone therapy to a Duchenne muscular dystrophy patient with advanced congestive heart failure]. Matsumura T; Saito T; Miyai I; Nozaki S; Kang J Rinsho Shinkeigaku; 1999 Jun; 39(6):643-8. PubMed ID: 10502990 [TBL] [Abstract][Full Text] [Related]
15. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure]. Dong H; Chen DQ; Wang Y; Li M Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908 [TBL] [Abstract][Full Text] [Related]
16. [Vasodilator hormonal agents in chronic heart failure: effect of angiotensin-converting enzyme inhibitors]. Godoy I; Corbalán R; Jalil J; Guarda E; Albertini R Rev Med Chil; 1997 Feb; 125(2):135-42. PubMed ID: 9430932 [TBL] [Abstract][Full Text] [Related]
17. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure]. Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600 [TBL] [Abstract][Full Text] [Related]
18. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure. Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553 [TBL] [Abstract][Full Text] [Related]
19. [Management of myocardial damage in muscular dystrophy]. Tamura T Brain Nerve; 2011 Nov; 63(11):1217-28. PubMed ID: 22068474 [TBL] [Abstract][Full Text] [Related]
20. Plasma concentration of atrial natriuretic peptide is related to the duration of atrial fibrillation in patients with advanced heart failure. Wozakowska-Kapłon B; Opolski G; Janion M; Kosior D Kardiol Pol; 2004 Dec; 61(12):513-21; discussion 522. PubMed ID: 15815752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]